Thiazolidinedione drugs are used for the treatment of type II diabetes mellitus and increase insulin sensitivity through a putative mechanism involving activation of PPARs which may influence mitochondrial mass or network architecture (eeviewed by Nanjan et al. [136]). The gene discussed is INS; the disease is type 2 diabetes mellitus.